Literature DB >> 8703038

The initiator element and proximal upstream sequences affect transcriptional activity and start site selection in the amyloid beta-protein precursor promoter.

W W Quitschke1, J P Matthews, R J Kraus, A A Vostrov.   

Abstract

The TATA-less human amyloid beta-protein precursor promoter contains an initiator element with the sequence CGTCA+1GTT. Primary transcriptional start sites were identified at positions +1 and -4. Deletion of the upstream activator elements APBbeta and APBalpha did not affect the selection of transcriptional start sites, although total transcriptional activity was reduced both in vitro and in vivo. Mutations within the initiator element shifted the transcriptional start sites and reduced transcriptional activity. Mutations between positions -6 and -35 changed the relative utilization of start sites +1 and -4 without affecting the total level of transcriptional activity. A 10-base pair deletion between position -40 and -31 increased in vitro transcriptional activity with a preeminent utilization of the start site at position -4. In contrast, a 20-base pair deletion between position -40 and -21 resulted in a reduction in transcriptional activity and in the primary utilization of the start site at position +1. Furthermore, transactivation by APBbeta and APBalpha was eliminated. DNase I footprinting provided evidence for the existence of two binding domains designated UE (position -12 to -30) and Inr (position +7 to -7). The positions of these binding domains are altered in mutations and deletions that affect transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703038     DOI: 10.1074/jbc.271.36.22231

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Differential effect of zinc finger deletions on the binding of CTCF to the promoter of the amyloid precursor protein gene.

Authors:  W W Quitschke; M J Taheny; L J Fochtmann; A A Vostrov
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

2.  A nuclear factor-binding domain in the 5'-untranslated region of the amyloid precursor protein promoter: implications for the regulation of gene expression.

Authors:  Alexander A Vostrov; Michael J Taheny; Nerik Izkhakov; Wolfgang W Quitschke
Journal:  BMC Res Notes       Date:  2010-01-12

3.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.

Authors:  Jessie Theuns; Nathalie Brouwers; Sebastiaan Engelborghs; Kristel Sleegers; Veerle Bogaerts; Ellen Corsmit; Tim De Pooter; Cornelia M van Duijn; Peter P De Deyn; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2006-04-10       Impact factor: 11.025

4.  Thyroid hormone-regulated enhancer blocking: cooperation of CTCF and thyroid hormone receptor.

Authors:  Marcus Lutz; Les J Burke; Pascal LeFevre; Fiona A Myers; Alan W Thorne; Colyn Crane-Robinson; Constanze Bonifer; Galina N Filippova; Victor Lobanenkov; Rainer Renkawitz
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

5.  Two adjacent nuclear factor-binding domains activate expression from the human PRNP promoter.

Authors:  Michael J Taheny; Nerik Izkhakov; Alexander A Vostrov; Wolfgang W Quitschke
Journal:  BMC Res Notes       Date:  2009-09-09

Review 6.  Transcriptional regulation and its misregulation in Alzheimer's disease.

Authors:  Xiao-Fen Chen; Yun-wu Zhang; Huaxi Xu; Guojun Bu
Journal:  Mol Brain       Date:  2013-10-21       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.